Teleflex IncTFX

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$120.09
Market cap
$5.1B
P/E
—
Revenue (TTM)
$2.3B
Net income
-$1.0B
Dividend yield
1.13%
1-year total return
3.8%
Net margin
-45.8%
Revenue growth
30.7%
Debt / equity
0.97x

What Teleflex Inc does.

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Because our products are used in numerous markets and for a variety of procedures, we are not dependent upon any one end-market or procedure. Our major manufacturing operations are located in the Czech Republic, Malaysia, Mexico and the United States (the "U.S.").

We are focused on achieving consistent, sustainable and profitable growth and improving our financial performance by increasing our market share and improving our operating efficiencies through:

• achievement of economies of scale as we continue to expand by utilizing our direct sales force and distribution network to sell new products, as well as by increasing efficiencies in our sales and marketing organizations, research and development activities and manufacturing and distribution facilities; and

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$2.5B$2.8B$2.8B$1.7B$1.7B$2.0B
Net income$335.3M$485.4M$363.1M$356.3M$69.7M-$905.6M
Free cash flow$346.4M$580.5M$263.6M$159.7M$211.4M$1.4M

More on TFX.

Figures from Teleflex Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.